
Multidisciplinary recommendations aim to standardize the use of intestinal ultrasound to assess postoperative Crohn’s disease recurrence, published online in The Lancet Gastroenterology & Hepatology.
Christopher Ma, M.D., from The Cumming School of Medicine in Calgary, Alberta, Canada, and colleagues developed expert-based recommendations for standardizing intestinal ultrasound use for the detection and evaluation of postoperative Crohn disease recurrence after surgical bowel ileocolic resection. A list of statements related to the use of intestinal ultrasound in this setting was generated; the appropriateness of each statement was rated in two rounds of voting and classified as appropriate, inappropriate, or uncertain, and then ratified.
The researchers found that during the ratification meeting, 79 statements were voted on; 67 were ratified. The colonic segment immediately distal to the anastomosis, the neoterminal ileum, neoterminal ileal inlet, colonic and ileal blind side of the anastomosis, sonographically visible colonic segments, and the surrounding mesentery were recommended anatomical components for sonographic evaluation. For parameters of assessment, the authors recommended bowel wall thickness, bowel wall stratification, bowel wall vascularity, mesenteric inflammatory fat and lymphadenopathy, luminal narrowing, and the presence of complications (abscess, inflammatory mass, fistula or sinus tract, stricture and stricture length, and prestenotic dilation). To avoid confounding the interpretation of sonographic findings with immediate postoperative complications or changes associated with surgical healing, waiting at least four weeks after surgery to perform intestinal ultrasound was recommended.
“The guidance developed through this consensus aims to enhance consistency, diagnostic accuracy, and confidence in applying intestinal ultrasound to clinical practice and research settings,” the authors write.
Several authors disclosed ties to biopharmaceutical companies, including Johnson & Johnson Innovative Medicine, which funded the research.
Black patients with inflammatory bowel disease (IBD) often experience delays in diagnosis and specialty care compared with white patients. Access to gastroenterologists, IBD specialists, advanced imaging, and biologic therapies can vary by geography and socioeconomic factors.
Standardized postoperative assessment protocols may help reduce variability in follow-up care for patients with Crohn’s disease. Consistent post-surgery surveillance is especially important for patients at risk of gaps in care.
The new recommendations rely on timely follow-up evaluations, endoscopy, biomarkers, and imaging. Healthcare systems should examine whether all patient populations have equal access to these services. Missed appointments, insurance barriers, transportation challenges, and specialist shortages can affect long-term disease management. For clinicians, identifying recurrence earlier may allow intervention before symptoms worsen.
Variability in postoperative surveillance can contribute to differences in outcomes. The new recommendations provide a framework for more consistent care for patients with Crohn’s disease. As the gastrointestinal disease continues to rise among historically underrepresented populations, ensuring guideline-based follow-up for all patients will be increasingly important.
Future studies should continue examining outcomes across diverse patient populations.
Abstract/Full Text (subscription or payment may be required)
By subscribing, you consent to receive emails from BlackDoctor.pro You may unsubscribe at any time. Privacy Policy & Terms of Service.
Are you a healthcare professional? Register with us today!